These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12739275)

  • 1. The war against an unknown pathogen: rising to the SARS challenge.
    Can Commun Dis Rep; 2003 May; 29(9):77-82. PubMed ID: 12739275
    [No Abstract]   [Full Text] [Related]  

  • 2. [SARS: a new emergency in the world health].
    Calza L; Manfredi R; Verucchi G; Chiodo F
    Recenti Prog Med; 2003; 94(7-8):284-94. PubMed ID: 12868233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral treatment of SARS: can we draw any conclusions?
    Zhaori G
    CMAJ; 2003 Nov; 169(11):1165-6. PubMed ID: 14638651
    [No Abstract]   [Full Text] [Related]  

  • 4. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada.
    Knowles SR; Phillips EJ; Dresser L; Matukas L
    Clin Infect Dis; 2003 Oct; 37(8):1139-42. PubMed ID: 14523782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials and novel pathogens: lessons learned from SARS.
    Muller MP; McGeer A; Straus SE; Hawryluck L; Gold WL
    Emerg Infect Dis; 2004 Mar; 10(3):389-94. PubMed ID: 15109402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribavirin in the treatment of severe acute respiratory syndrome (SARS).
    van Vonderen MG; Bos JC; Prins JM; Wertheim-van Dillen P; Speelman P
    Neth J Med; 2003 Jul; 61(7):238-41. PubMed ID: 14567520
    [No Abstract]   [Full Text] [Related]  

  • 7. [Severe acute respiratory syndrome: the first transmissible disease of the 21st century].
    Nicastri E; Petrosillo N; Macrì G; Ippolito G
    Recenti Prog Med; 2003; 94(7-8):295-303. PubMed ID: 12868234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribavirin trials and hantavirus--what we should not conclude.
    Marcus KA; Johann-Liang R; Powers JH
    Clin Infect Dis; 2005 May; 40(10):1550-1. PubMed ID: 15844085
    [No Abstract]   [Full Text] [Related]  

  • 9. [Severe acute respiratory syndrome (SARS). Local infection--global panic].
    Ekdahl K; Giesecke J; Linde A
    Lakartidningen; 2003 Apr; 100(16):1420-2, 1425. PubMed ID: 12756709
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of severe acute respiratory syndrome on the use of and requirements for filters in Canada.
    Thiessen RJ
    Respir Care Clin N Am; 2006 Jun; 12(2):287-306. PubMed ID: 16828696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS outbreak and lessons learned.
    Engman ML
    J Insur Med; 2002; 34(2):83-5. PubMed ID: 15305781
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical brief: severe acute respiratory syndrome (SARS).
    Buckley H
    AAOHN J; 2003 Jul; 51(7):303-5. PubMed ID: 12880233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe acute respiratory syndrome (SARS).
    Fla Nurse; 2003 Jun; 51(2):5. PubMed ID: 12858740
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.
    Muller MP; Dresser L; Raboud J; McGeer A; Rea E; Richardson SE; Mazzulli T; Loeb M; Louie M;
    Pharmacotherapy; 2007 Apr; 27(4):494-503. PubMed ID: 17381375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of corticosteroids in SARS.
    Oba Y
    N Engl J Med; 2003 May; 348(20):2034-5; author reply 2034-5. PubMed ID: 12748321
    [No Abstract]   [Full Text] [Related]  

  • 16. Ribavarin should be tested in clinical trials in combination with other antiviral agents for severe acute respiratory syndrome.
    Chu CM; Chan KS
    Chest; 2005 Dec; 128(6):4050. PubMed ID: 16354884
    [No Abstract]   [Full Text] [Related]  

  • 17. Will SARS strike here?
    Lemonick MD
    Time; 2003 Apr; 161(15):72-5. PubMed ID: 12698644
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe acute respiratory syndrome.
    Ziskin LZ
    N J Med; 2003 Jun; 100(6):11. PubMed ID: 12854428
    [No Abstract]   [Full Text] [Related]  

  • 19. Pro/con clinical debate: steroids are a key component in the treatment of SARS. Con: No, steroids are not a key component of the treatment regimen for SARS.
    Kargel MJ; Lapinsky SE
    Crit Care; 2004 Apr; 8(2):105-7. PubMed ID: 15515216
    [No Abstract]   [Full Text] [Related]  

  • 20. [How did we handle suspected cases of SARS? Did alarming media reports frighten health personnel?].
    Karlberg J
    Lakartidningen; 2004 Aug; 101(34):2586-7. PubMed ID: 15446700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.